Founded in 2015, Airdoc is committed to " More Intelligence???Better Care" providing comprehensive artificial intelligence (AI) solutions for early screening and management of chronic diseases, myopia prevention and control, treatment of strabismus and amblyopia, and stress resilience assessment. As a global leader in the field of retinal image AI, Airdoc is also the first enterprise in China to obtain Class III medical device registration for AI-assisted diagnosis of fundus diseases from the National Medical Products Administration (NMPA).